During the past decade, Lake Region Healthcare Corporation-Cancer Care conducted 94 clinical trials. In the 10-year time frame, 94 clinical trials started and 51 clinical trials were completed, i.e. on average, 54.3% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 38 clinical trials were completed. i.e. 122.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lake Region Healthcare Corporation-Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 65 trials, followed by "SWOG Cancer Research Network" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "Wake Forest University Health Sciences" with 12 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lake Region Healthcare Corporation-Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 64 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Lake Region Healthcare Corporation-Cancer Care" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Lake Region Healthcare Corporation-Cancer Care" in a lesser frequency.

Most popular intervention types in "Lake Region Healthcare Corporation-Cancer Care" are "Drug" (106 trials), "Other" (80 trials), "Biological" (62 trials), "Procedure" (36 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Quality-of-Life Assessment" (30 trials), "Computed Tomography" (20 trials), "Nivolumab" (19 trials) and "Biospecimen Collection" (16 trials). Other intervention names were less common.

The vast majority of trials in "Lake Region Healthcare Corporation-Cancer Care" are 112 trials for "All" genders, 13 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Lake Region Healthcare Corporation-Cancer Care". undefined are not yet recruiting, 34 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Lake Region Healthcare Corporation-Cancer Care, 4 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Lake Region Healthcare Corporation-Cancer Care, 5 "Phase 1" clinical trials were conducted, 65 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".